Brief: Ck Life Sciences Intl Posts HY Unaudited Profit Attributable HK$37 Million
Aug 1 (Reuters) - CK Life Sciences Intl (Holdings) Inc
0775.HK :
* HY UNAUDITED PROFIT ATTRIBUTABLE TO SHAREHOLDERS OF AROUND
HK$37
MILLION, A DECLINE OF 43%
* HY REVENUE HK$2.58 BILLION VERSUS HK$2.54 BILLION
Source text for Eikon: ID:nHKS4CBCmq
Further company coverage: 0775.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CK Life Sciences Intl (Holdings)
See all newsCK Life Sciences H1 loss narrows on lower R&D costs
Brief: CK Life Sciences Intl Announces Resignation Of Lance Richard Lee Yuen As Executive Director, CEO
Brief: CK Life Sciences Intl Logs FY Loss Attributable HK$186.8 Mln
CK Life Sciences rises most in 4 months on advancing cancer vaccine development
Brief: CK Life Sciences Intl Establishes Sequencio Therapeutics For Cancer Vaccine Development